Laboratory Reference Grade Compounds

Tesamorelin

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱3,150.00
In Stock · Dispatches 24h
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (10MG)
Diluent:mL
Concentration10.00 mg/mLin 1.0mL BAC
Standard Dose1.0 mg – 2.0 mg dailySyringe: 20.0 units (0.20 mL)
Scale (1 Unit)100 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
Tesamorelin10MG · TESA 10MG
₱3,150.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: Tesamorelin is a synthetic 44-amino-acid peptide analogue of Growth Hormone-Releasing Hormone (GHRH), modified with a trans-3-hexenoic acid moiety at its N-terminus for enhanced metabolic stability.

How it works: It acts on the pituitary gland to stimulate natural, pulsatile growth hormone release with remarkable potency. Uniquely among GHRH analogues, Tesamorelin specifically targets and reduces deep visceral adipose tissue (the dangerous fat packed around internal organs like the liver, heart, and intestines).

Why researchers study it: Studied for visceral belly fat reduction, non-alcoholic fatty liver disease (NAFLD), improving cardiovascular risk markers, and enhancing cognitive function in aging subjects.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryGrowth Hormone Axis
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number218949-48-5
PubChem CID16137828↗
Molecular Weight5135.86 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options10MG
Inclusion PackagesTESA 10MG
Peptide Sequence / FormulaC221H366N72O67S (Trans-3-hexenoyl-GHRH 1-44)